Intravenous Immunoglobulin Market 2022
Intravenous Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is administered into the bloodstream to treat patients with inefficient or damaged immune systems. IVIg provides the required antibodies by the human body to fight out the immune deficiency, and the ensuing infectious attacks.
The global Intravenous Immunoglobulin Market Size has been evaluated as moderately growing market and it is expected that the market will continue to grow similarly in the near future. The demand for new products and therapy is growing continuously. The market for Intravenous Immunoglobulin (IVIg) was around US$ 5910.8 million in 2016 and is expected to grow at a CAGR of 5.9% during forecast.
Immunodeficiency disorder could be a hereditary issue (Primary disorders), or caused due to the exposure to infections, mainly through bodily fluids, along with the cancer drugs and chemotherapy, aging is one of the key risk factors too that could put someone at higher risk of a damaged immune system.
People nowadays are increasingly adopting heady & unhealthy lifestyles which mirror the prevalence of damaged immune system. Factors such as immense stress, lack of good quality sleep, inadequate & improper diet and sedentary lifestyle are fuelling the prevalence of immunodeficiency disorder and therefore, predominantly driving the growth of the market.
Major Key Players:
There are plenty of large and small market players which operate in this market: ABEONA THERAPEUTICS (US), Baxter (US), BDI Pharma (US), Biotest AG.(Germany),, China Biologic Products, Inc. (China), CSL Behring (US), Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma (Switzerland), Shire (Republic of Ireland), AND others.
Intravenous Immunoglobulin (IVIg) Market has been segmented on the basis of type which comprise Plaque psoriasis, Scalp psoriasis, Nail psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis, Erythrodermic psoriasis and others. Plaque psoriasis is most common type and about 80% of the cases are plaque psoriasis. On the basis of immunoglobulin therapy treatment type it segmented into Topical corticosteroids, Vitamin D analogues (Calcipotriene, Calcitriol), Anthralin, Topical retinoids (Retinol, Tretinoin (retinoic acid / retin-A /Steiva-A), Adapalene (Differin), Tazarotene), Calcineurin inhibitors (tacrolimus (Prograf), pimecrolimus (Elidel)), Salicylic acid, Coal tar, Moisturizers, and Others. Vitamin D analogs such as Calcipotriene and Calcitriol very helpful and helps to slow skin cell growth. Topical retinoids like are Retinol, Tretinoin (retinoic acid / retin-A /Steiva-A), Adapalene (Differin), Tazarotene are vitamin A derivatives that helps to reduce inflammation.
The North American region, heading with the presence of a large number of key players and a well-established healthcare sector accounts for the leading market in the global IVIg market.
The US market backed by the high expenditure on healthcare accounts for the largest contributor to the growth of the regional market. Moreover, the increasing prevalence of immunodeficiency disorder and rising demand for treatment measures provide impetus to market growth.
The Intravenous Immunoglobulin Market in the European region accounts for the second-largest market, globally.
The IVIg market in Europe is fostered by the high per capita income and robust healthcare penetration in the region. The strong market growth in countries like Germany & France drives the regional market growth, large scale. Moreover, factors such as the increasing investments in healthcare and the rising number of patients with immune system diseases are helping the market to create a larger revenue pocket.
The Asia Pacific Intravenous Immunoglobulin Market is expected to perceive an exponential growth. Factors such as the vast population and the burgeoning medical treatment market, especially in India & China, drive the growth of the regional market. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the market growth in the region. With the growing Medical Tourism markets in India & Malaysia, the APAC region will register a significant CAGR during the review period.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312